Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, signaling a small backend or content update.
    Difference
    0.0%
    Check dated 2026-08-29T18:49:51.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added to the page, indicating an update to the study record. A large set of core trial details, including the listed interventions (Nivolumab, Losartan, FOLFIRINOX) and related MeSH terms, were removed from the study record, altering the displayed scope of the trial.
    Difference
    21%
    Check dated 2026-08-08T19:26:48.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added, replacing the previous Revision: v3.6.3 in the page's study record dates.
    Difference
    0.0%
    Check dated 2026-07-25T11:38:46.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    No changes were recorded for this page. The study overview, design, and eligibility criteria remain as published.
    Difference
    0.0%
    Check dated 2026-07-18T05:18:28.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study record revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. The change reflects an incremental update to the publicly posted record rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-03T22:16:59.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Site revision updated from v3.6.0 to v3.6.2, reflecting a backend platform update on the study page. No study details or navigation are affected.
    Difference
    0.0%
    Check dated 2026-06-27T00:01:25.000Z thumbnail image

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.